Seelos Therapeutics Revenue, Growth & Competitor Profile

DBA APRICUS
DBA APRICUS BIOSCIENCES, INC.

Company Profile & Annual Report for Seelos Therapeutics

Access the complete profile.

Seelos Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address	300 Park Ave Fl 12 New York, NY 10022

Note: Revenues for privately held companies are statistical evaluations.


Seelos Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Seelos Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Seelos Therapeutics is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Seelos Therapeutics Annual Revenue and Growth Rate

Seelos Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Seelos Therapeutics's revenues are gauged from an analysis of company filings.

Seelos Therapeutics's Income Statement (based on Industry Averages)

Seelos Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Seelos Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Seelos Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Seelos Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
HARRY'S	New York, NY	100
PSL GROUP	New York, NY	67
LG H&H USA	New York, NY	9
LAURICE EL BADRY RAHME LTD D B A	New York, NY	8
MEIYUME USA	New York, NY	8
DEVA CONCEPTS	New York, NY	6

Other Companies at 300 Park Ave, New York NY

Company	Headquarters	Revenue ($ MM)
COLGATE-PALMOLIVE	New York, NY	100
JLL PARTNERS FCH	New York, NY	0
AIERA	New York, NY	0
CROWDBUREAU	New York, NY	0
SUMITOMO MITSUI DS ASSET MANAGEMENT USA	New York, NY	0

Future Competition: Seelos Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Seelos Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)